bianca
@biancasocially.bsky.social
Reposted by bianca
Anj's family history of breast cancer led her to early mammogram screenings and her diagnosis. Today, she's using Signatera™ with her care team to monitor for recurrence.
Watch her full story here: ow.ly/cpfR50Xojqr
#Natera
Watch her full story here: ow.ly/cpfR50Xojqr
#Natera
November 7, 2025 at 12:51 PM
Anj's family history of breast cancer led her to early mammogram screenings and her diagnosis. Today, she's using Signatera™ with her care team to monitor for recurrence.
Watch her full story here: ow.ly/cpfR50Xojqr
#Natera
Watch her full story here: ow.ly/cpfR50Xojqr
#Natera
Reposted by bianca
Natera’s technology will be featured in 14 studies at the ESMO - European Society for Medical Oncology Congress, including 6 oral presentations. We look forward to connecting at #ESMO25 as we continue advancing personalized, MRD-guided cancer care for patients everywhere.
https://ow.ly/XJ1x50XaKc1
https://ow.ly/XJ1x50XaKc1
October 13, 2025 at 7:40 PM
Natera’s technology will be featured in 14 studies at the ESMO - European Society for Medical Oncology Congress, including 6 oral presentations. We look forward to connecting at #ESMO25 as we continue advancing personalized, MRD-guided cancer care for patients everywhere.
https://ow.ly/XJ1x50XaKc1
https://ow.ly/XJ1x50XaKc1
Grateful to be part of a mission that puts people first and science to work where it matters most.
Learn more about Signatera and the foundational technology that is transforming care for patients with cancer. Hear from #Natera CEO Steve Chapman on how Signatera can detect molecular residual disease and help determine whether therapy is working. youtu.be/fLkJlNzL3hU
#CancerCare #Signatera
#CancerCare #Signatera
Signatera™: A Personalized Test for Molecular Residual Disease Detection
YouTube video by Natera
youtu.be
May 30, 2025 at 5:20 PM
Grateful to be part of a mission that puts people first and science to work where it matters most.
Reposted by bianca
With the news that Medicare will cover Signatera for stage I-III non-small cell lung cancer in surveillance, Signatera is now more accessible to patients living with lung cancer–the most lethal and one of the most common forms of cancer in the U.S. www.natera.com/company/news... #Natera
Natera Announces Medicare Coverage of Signatera™ for Surveillance in Lung Cancer
AUSTIN, Texas–(BUSINESS WIRE)– Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA and genetic testing, today announced that its Signatera test has met coverage requirements from the Centers...
www.natera.com
February 25, 2025 at 4:24 PM
With the news that Medicare will cover Signatera for stage I-III non-small cell lung cancer in surveillance, Signatera is now more accessible to patients living with lung cancer–the most lethal and one of the most common forms of cancer in the U.S. www.natera.com/company/news... #Natera
So proud to be part of an organization that prioritizes giving back! #Natera
We reached our 2025 volunteerism goal early, contributing 20k volunteer hours in support of nonprofit partners across the country! We’re proud of this positive impact on our community in honor of our core value "be ready to change the world." 🌎💚 #TeamNatera #Natera #Volunteer
November 25, 2024 at 7:07 PM
So proud to be part of an organization that prioritizes giving back! #Natera
shout out to everyone working from their parents’ kitchen this week
November 25, 2024 at 3:56 PM
shout out to everyone working from their parents’ kitchen this week
Reposted by bianca
#Natera's journey: From IVF to pioneering genetic diagnostics. Mission-driven innovation transforming healthcare through interdisciplinary breakthroughs. Founders Matthew Rabinowitz & Jonathan Sheena, CEO Steve Chapman share on Sequoia #CrucibleMoments podcast.
ow.ly/eatK50UcfZh
#GeneticTesting
ow.ly/eatK50UcfZh
#GeneticTesting
Natera ft. Matthew Rabinowitz - A Personal Mission That Led to a Biotech Revolution
Founder Matthew Rabinowitz opens up about the intensely personal journey that set him on a course to revolutionizing healthcare.
www.sequoiacap.com
November 21, 2024 at 9:12 PM
#Natera's journey: From IVF to pioneering genetic diagnostics. Mission-driven innovation transforming healthcare through interdisciplinary breakthroughs. Founders Matthew Rabinowitz & Jonathan Sheena, CEO Steve Chapman share on Sequoia #CrucibleMoments podcast.
ow.ly/eatK50UcfZh
#GeneticTesting
ow.ly/eatK50UcfZh
#GeneticTesting